Lipopolysaccharide promotes lipid accumulation in human adventitial fibroblasts via TLR4-NF-B pathway

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Wang, Jun ^a   Si, Yanfang ^b   Wu, Chen ^a   Sun, Lu ^a   Ma, Yudong ^a   Ge, Aili ^a   Li, Baomin ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b 309TH HOSPITAL OF PLA   (China)

Author keywords

ADRP; Adventitial fibroblasts; Atherosclerosis; Lipid accumulation; LPS; Toll like receptor 4

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; FAT DROPLET; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; PYRROLIDINE DITHIOCARBAMATE; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE SILENCING; GENE TRANSLOCATION; HUMAN; HUMAN CELL; LIPID ANALYSIS; LIPID STORAGE; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

ADVENTITIA; ATHEROSCLEROSIS; BASE SEQUENCE; CELLS, CULTURED; CHEMOKINE CCL2; FIBROBLASTS; HUMANS; LIPID METABOLISM; LIPOPOLYSACCHARIDES; MEMBRANE PROTEINS; NF-KAPPA B; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

BACTERIA (MICROORGANISMS);

EID: 84867474129     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-139     Document Type: Article

References (44)

1. Inflammation, atherosclerosis, and coronary artery disease. Hansson GK, N Engl J Med 2005 352 1685 1695 10.1056/NEJMra043430 15843671 (Pubitemid 40530235)
2. INTER-HEART: A global study of risk factors for acute myocardial infarction. Ounpuu S, Negassa A, Yusuf S, Am Heart J 2001 141 711 721 10.1067/mhj.2001.114974 11320357 (Pubitemid 32378478)
3. The global epidemic of atherosclerotic cardiovascular disease. Yusuf S, unpuu S, Anand S, Medical Principles and Practice 2002 11 3 8 10.1159/000066416 12444305 (Pubitemid 35365368)
4. Inflammation and atherosclerosis. Libby P, Ridker PM, Maseri A, Circulation 2002 105 1135 1143 10.1161/hc0902.104353 11877368 (Pubitemid 34212626)
5. Nox4 Oxidase Overexpression Specifically Decreases Endogenous Nox4 mRNA and Inhibits Angiotensin II-Induced Adventitial Myofibroblast Migration. Haurani MJ, Cifuentes ME, Shepard AD, Pagano PJ, Hypertension 2008 52 143 149 10.1161/HYPERTENSIONAHA.107.101667 18474828
6. The role of adventitia in atherosclerosis. Liu ZY, Kong W, Sheng Li Ke Xue Jin Zhan 2010 41 177 182 21416976
7. Adipose tissue, inflammation, and cardiovascular disease. Berg AH, Scherer PE, Circ Res 2005 96 939 949 10.1161/01.RES.0000163635.62927.34 15890981 (Pubitemid 40712793)
8. Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice. Recinos A, LeJeune WS, Sun H, Lee CY, Tieu BC, Lu M, Hou T, Boldogh I, Tilton RG, Brasier AR, Atherosclerosis 2007 194 125 133 10.1016/j.atherosclerosis.2006.10.013 17109863 (Pubitemid 47464314)
9. Arginase I attenuates inflammatory cytokine secretion induced by lipopolysaccharide in vascular smooth muscle cells. Wang XP, Chen YG, Qin WD, Zhang W, Wei SJ, Wang J, Liu FQ, Gong L, An FS, Zhang Y, et al. Arterioscler Thromb Vasc Biol 2011 31 1853 1860 10.1161/ATVBAHA.111.229302 21617140
10. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M, Trends Immunol 2001 22 199 204 10.1016/S1471- 4906(01)01863-4 11274925 (Pubitemid 32673659)
11. Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation. Ostos MA, Recalde D, Zakin MM, Scott-Algara D, FEBS Lett 2002 519 23 29 10.1016/S0014-5793(02)02692-3 12023012 (Pubitemid 34521986)
12. Lipopolysaccharide associates with pro-atherogenic lipoproteins in periodontitis patients. Kallio KA, Buhlin K, Jauhiainen M, Keva R, Tuomainen AM, Klinge B, Gustafsson A, Pussinen PJ, Innate Immun 2008 14 247 253 10.1177/1753425908095130 18669610
13. Immunopathogenesis of Atherosclerosis Endotoxin Accelerates Atherosclerosis in Rabbits on Hypercholesterolemic Diet. Lehr HA, Sagban TA, Ihling C, Zähringer U, Hungerer KD, Blumrich M, Reifenberg K, Bhakdi S, Circulation 2001 104 914 920 10.1161/hc3401.093153 11514379 (Pubitemid 32778043)
14. In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions. Vink A, Schoneveld AH, van der Meer JJ, Van Middelaar BJ, Sluijter JPG, Smeets MB, Quax PHA, Lim SK, Borst C, Pasterkamp G, Circulation 2002 106 1985 1990 10.1161/01.CIR.0000032146.75113.EE 12370224 (Pubitemid 35176306)
15. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB, Arditi M, Proc Natl Acad Sci USA 2004 101 10679 10684 10.1073/pnas.0403249101 15249654 (Pubitemid 38955802)
16. Melittin Inhibits Atherosclerosis in LPS/High-Fat Treated Mice Through Atheroprotective Actions. Kim S, Park J, Kim K, Lee W, Kim K, Park K, J Atheroscler Thromb 2011 18 1117 1126 10.5551/jat.8474 22008474
17. More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome-sub-analysis of JAPAN-ACS study. Arai H, Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Kimura K, Saito S, J Atheroscler Thromb 2010 17 1096 1107 10.5551/jat.5660 20675955
18. Lipid glycation and protein glycation in diabetes and atherosclerosis. Miyazawa T, Nakagawa K, Shimasaki S, Nagai R, Amino Acids 2012 42 1163 1170 10.1007/s00726-010-0772-3 20957396
19. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, JAMA 2004 291 1071 1080 10.1001/jama.291.9.1071 14996776 (Pubitemid 38541684)
20. Deficiency of adipose differentiation-related protein impairs foam cell formation and protects against atherosclerosis. Paul A, Chang BHJ, Li L, Yechoor VK, Chan L, Circ Res 2008 102 1492 1501 10.1161/CIRCRESAHA.107.168070 18483409
21. Lipopolysaccharide up-regulates the expression of Fc/ receptor and promotes the binding of oxidized low-density lipoprotein and its IgM antibody complex to activated human macrophages. Feng X, Zhang Y, Xu R, Xie X, Tao L, Gao H, Gao Y, He Z, Wang H, Atherosclerosis 2010 208 396 405 10.1016/j. atherosclerosis.2009.07.035 19682689
22. Aortic adventitial fibroblasts participate in angiotensin-induced vascular wall inflammation and remodeling. Tieu BC, Ju X, Lee C, Sun H, Lejeune W, Recinos A, Brasier AR, Tilton RG, J Vasc Res 2011 48 261 272 10.1159/000320358 21099231
23. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-B dependent inflammatory response. Boyd JH, Mathur S, Wang Y, Bateman RM, Walley KR, Cardiovasc Res 2006 72 384 393 10.1016/j.cardiores. 2006.09.011 17054926 (Pubitemid 44665856)
24. Toll-like receptor 4 polymorphisms and atherogenesis. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA, N Engl J Med 2002 347 185 192 10.1056/NEJMoa012673 12124407 (Pubitemid 34764822)
25. The myofibroblast: a quarter century after its discovery. Schürch W, Seemayer TA, Gabbiani G, Am J Surg Pathol 1998 22 141 147 10.1097/00000478- 199802000-00001 9500214
26. PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts. Simonin MA, Bordji K, Boyault S, Bianchi A, Gouze E, Becuwe P, Dauca M, Netter P, Terlain B, Am J Physiol Cell Physiol 2002 282 125 C133 11742805 (Pubitemid 34662559)
27. Induction of interleukin-1 and-6 in human gingival fibroblast cultures stimulated with Bacteroides lipopolysaccharides. Takada H, Mihara J, Morisaki I, Hamada S, Infect Immun 1991 59 295 301 1702762
28. Chronic Helicobacter pylori infection is associated with peripheral arterial disease. Sawayama Y, Hamada M, Otaguro S, Maeda S, Ohnishi H, Fujimoto Y, Taira Y, Hayashi J, J Infect Chemother 2008 14 250 254 10.1007/s10156-008- 0613-4 18574664 (Pubitemid 351875927)
29. The relationship between Chlamydophila pneumoniae IgG titer and coronary atherosclerosis. Kalay N, Kutukoglu I, Ozdogru I, Kilic H, Cetinkaya Y, Eryol N, Karakaya E, Oguzhan A, Cardiol J 2008 15 245 251 18651417
30. Role of heat shock proteins in atherosclerosis. Xu Q, Arterioscler Thromb Vasc Biol 2002 22 1547 1559 10.1161/01.ATV.0000029720.59649.50 12377729
31. CD1 expression in human atherosclerosis: a potential mechanism for T cell activation by foam cells. Melián A, Geng YJ, Sukhova GK, Libby P, Porcelli SA, Am J Pathol 1999 155 775 786 10.1016/S0002-9440(10)65176-0 10487835 (Pubitemid 29426823)
32. Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Ball R, Stowers E, Burton J, Cary N, Skepper J, Mitchinson M, Atherosclerosis 1995 114 45 54 10.1016/0021-9150(94)05463-S 7605375
33. Transforming growth factor-1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants. Argmann CA, Van Den Diepstraten CH, Sawyez CG, Edwards JY, Hegele RA, Wolfe BM, Huff MW, Arterioscler Thromb Vasc Biol 2001 21 2011 2018 10.1161/hq1201.099426 11742878 (Pubitemid 34219755)
34. Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins. OBrien KD, Olin KL, Alpers CE, Chiu W, Ferguson M, Hudkins K, Wight TN, Chait A, Circulation 1998 98 519 527 10.1161/01.CIR.98.6.519 9714108 (Pubitemid 28371249)
35. Ablation of neutral cholesterol ester hydrolase 1 accelerates atherosclerosis. Sekiya M, Osuga J, Nagashima S, Ohshiro T, Igarashi M, Okazaki H, Takahashi M, Tazoe F, Wada T, Ohta K, et al. Cell Metab 2009 10 219 228 10.1016/j.cmet.2009.08.004 19723498
36. Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis. Upston JM, Niu X, Brown AJ, Mashima R, Wang H, Senthilmohan R, Kettle AJ, Dean RT, Stocker R, Am J Pathol 2002 160 701 710 10.1016/S0002-9440(10)64890-0 11839591 (Pubitemid 34160348)
37. Deletion of CCR2 but not CCR5 or CXCR3 inhibits aortic aneurysm formation. MacTaggart JN, Xiong W, Knispel R, Baxter BT, Surgery 2007 142 284 288 10.1016/j.surg.2007.04.017 17689697 (Pubitemid 47208561)
38. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. Ishibashi M, Hiasa K, Zhao Q, Inoue S, Ohtani K, Kitamoto S, Tsuchihashi M, Sugaya T, Charo IF, Kura S, Circ Res 2004 94 1203 1210 10.1161/01.RES. 0000126924.23467.A3 15059935 (Pubitemid 38659633)
39. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. Gosling J, Slaymaker S, Gu L, Tseng S, Zlot CH, Young SG, Rollins BJ, Charo IF, J Clin Invest 1999 103 773 778 10.1172/JCI5624 10079097 (Pubitemid 29152622)
40. MCP-1 deficiency is associated with reduced intimal hyperplasia after arterial injury. Kim WJH, Chereshnev I, Gazdoiu M, Fallon JT, Rollins BJ, Taubman MB, Biochem Biophys Res Commun 2003 310 936 942 10.1016/j.bbrc.2003.09. 088 14550294 (Pubitemid 37188712)
41. Upregulation of mRNA expression of MCP-1 by TGF-beta1 in fibroblast cells from Peyronies disease. Szardening-Kirchner C, Konrad L, Hauck EW, Haag SM, Eickelberg O, Weidner W, World J Urol 2009 27 123 130 10.1007/s00345-008-0320-x 18704440
42. Toll-like receptor 2-dependent NF-B activation is involved in nontypeable Haemophilus influenzae-induced monocyte chemotactic protein 1 up-regulation in the spiral ligament fibrocytes of the inner ear. Moon SK, Woo JI, Lee HY, Park R, Shimada J, Pan H, Gellibolian R, Lim DJ, Infect Immun 2007 75 3361 3372 10.1128/IAI.01886-06 17452470 (Pubitemid 47040937)
43. Rhizoma Coptidis inhibits LPS-induced MCP-1/CCL2 production in murine macrophages via an AP-1 and NFkappaB-dependent pathway. Remppis A, Bea F, Greten HJ, Buttler A, Wang H, Zhou Q, Preusch MR, Enk R, Ehehalt R, Katus H, Blessing E, Mediators Inflamm 2010 2010 194896 20652055
44. NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer. Calzado MA, Bacher S, Schmitz ML, Curr Med Chem 2007 14 367 376 10.2174/092986707779941113 17305539